Skip to main content
. 2019 Oct 24;11(20):8951–8968. doi: 10.18632/aging.102359

Figure 5.

Figure 5

LDLRAD2 activates Wnt/β-catenin signaling pathway by targeting Axin1 in GC. Co-immunoprecipitation assay showed that LDLRAD2 could bind to Axin1 (A). LDLRAD2 inhibited Axin1 from binding to β-catenin (BC).